HealthInnoNMSU Arrowhead Center
Innovation Commercialization Partnership Partner with us
HealthInno × NMSU Arrowhead Center

University IP innovations, built to impact the healthcare industry.

HealthInno partners with NMSU Arrowhead Center to bring breakthrough university IP to healthcare industry leaders — connecting investors and operators to validated, NMSU faculty-led inventions, from ultra-low-power heart monitoring to surfaces that keep their disinfectant, and providing the support to move them toward real-world adoption. Five are featured below.

Explore the innovations ↓ Partner with us
5
Technologies
Multi-$B
Every marketi
100%
NMSU-owned IP
Faculty-Led
NMSU innovations
NSF-funded research Peer-reviewed science Silicon-proven Patented / patent-pending · NMSU-owned

What this partnership represents

NMSU Arrowhead Center is New Mexico State University's innovation and entrepreneurship engine — home to the faculty inventions and patents below. HealthInno is the bridge to industry adoption: with funding support made possible by the New Mexico Economic Development Department, we back the most promising innovations and provide the pilot-readiness support that carries them from the lab into the hands of industry partners — driving economic transformation across New Mexico.

NMSU Arrowhead IPinvented & patented
→
HealthInnopilot-readiness support
→
Industry Partnerpilot & scale
→
NM Transformationstatewide economic impact
The Portfolio

Five inventions. Five markets.

An investor-level snapshot of each technology, a live peek at how it works, and the full brief and interactive demo one click away.

1Ultra-Low-Power SiliconSilicon-proven IP

Predictive Sensing ECG

Continuous heart monitoring at a fraction of the power

A signal-processing breakthrough that lets wearable ECG devices extract heartbeats and detect arrhythmias right at the sensor — predicting the signal and recording only the meaningful moments, so a patch can run for weeks on a coin cell.

Investor snapshot
720 nW
continuous ECG, proven in fabricated CMOSi
>99%
QRS accuracy on MIT-BIH databasei
$30B
wearable cardiac market by 2034 (~20%/yr)i
  • Drop-in licensable IP block — integrates into any sensor or SoC; not a device to manufacture.
  • Silicon-proven and validated; the same principle extends to EEG, EMG & other sparse signals.
Predictive sampling · live
U.S. Patents 12,431,913 · 12,551,155
Dr. Wei Tang · NMSU Arrowhead
2AAC · Assistive Technology2 U.S. Patents · to 2042

Beyond Words

An AAC board that reads the room and speaks for the patient

For people who can't speak, a communication board that senses place, people, and conversation and surfaces the right words, comments, and questions automatically — then speaks them aloud.

Investor snapshot
$3.5B
AAC market by 2035 · +64% growthi
1 in 4
autistic kids start school with <5 wordsi
1 in 3
devices abandoned year one — the gap this closesi
  • Patented context-aware core — incumbents are only now adding prediction; the method is already owned.
  • Runs on consumer tablets; clear reimbursement path via Medicaid, DME & school-AT funding.
Adaptive board · live
🎤 hears “pizza” · 📍 cafeteria
I want…
Suggested now
⌨️ Keyboard🔤 Core Words🏃 Actions👥 People🆘 Help
U.S. Patents 12,032,807 · 12,436,664
Zambrano & Wilson · NMSU Arrowhead
3Infection Control · MaterialsPatent application filed

Binary Surface (BIS)

A surface that keeps its disinfectant

Disinfectant on a flat surface is transient — it spreads, evaporates, or is wiped away. BIS is engineered at the micro- and nano-scale to hold a functional liquid by capillary force, so antimicrobial protection persists between cleanings. Preliminary lab tests: no detectable infectious virus at 1 h and 2 h for the disinfectant-infused version.

Investor snapshot
1 in 31
hospital patients has an HAI on any given dayi
$10–15B
antimicrobial coatings, ~11–13%/yr; healthcare is the largest segmenti
Replenish
not replace — re-infuse the liquid, keep the surfacei
  • Retained its liquid through shaking, flowing liquid, and wiping in preliminary lab tests; works with three formulations tested.
  • Built on NMSU's patented surface-modification method; a defined 5-month pilot-readiness plan — seeking a healthcare pilot site.
Flat vs. BIS · live
Patent application filed · NMSU
Dr. Sarada Kuravi · Dr. Krishna Kota · NMSU Arrowhead
Brief coming soon Explore demo →
4Clinical SimulationSoftware · instructor & student

ABG Simulation

Train respiratory-support decisions without risking a patient

An instructor sets a hidden disease scenario and starting blood gas; the student calculates ideal body weight, chooses support — room air, oxygen, high-flow, CPAP, BiPAP, or the ventilator — and watches the ABG respond in real time. Every decision is logged for debrief, and it works alongside existing mannequins or fully standalone.

Investor snapshot
$7B+
medical simulation by 2030 (~16%/yr)i
~17%
CAGR — web/virtual is the fastest segmenti
SaaS
software-only — infinite-scale margins
  • Closes a real skills gap — ABG & ventilator decisions intimidate frontline staff; recurring revenue into nursing, RT & med curricula.
  • Decision history for debrief, remediation & competency assessment; complements existing simulation equipment.
Live physiology · monitor
Dynamic Physiologic Simulation
Anthony Chasco, BS, RRT · NMSU Arrowhead
5Wearable DiagnosticsPeer-reviewed · ACS Sensors 2024

EcoCFTrack

A cystic-fibrosis sensor powered by the patient's motion

A flexible, skin-worn sweat sensor that harvests energy from body movement — no battery — to diagnose and continuously monitor cystic fibrosis against the clinical 60 mM chloride threshold, and tracks physical-therapy activity from that same motion.

Investor snapshot
Battery-free
triboelectric — the core differentiatori
~100K
global CF patients — underserved monitoringi
~34%
CAGR, wearable sweat-sensingi
  • Peer-reviewed (ACS Sensors 2024) — de-risked science, not a concept.
  • One band replaces three systems: diagnose + monitor + track; sits between $10–18B CF care & 34%-CAGR sweat sensing.
Self-powered sensing · live
CFTrack · ACS Sensors 2024
Dr. Gloria Zhang · NMSU Arrowhead

Bring one of these to market.

Each technology is NMSU-owned, validated, and available for licensing, co-development, or a clinical pilot. Let's talk about which fits your portfolio.

HealthInno
Joseph Sapien
Program Director
Joseph@htrx.io · 915.240.5571
NMSU Arrowhead Center
Patricia M. Knighten
Director, Innovation Commercialization · Office of Intellectual Property
pmk@nmsu.edu · 505.918.5974